Register for Webinar: Oligonucleotide Drugs: Key ADME & DMPK Insights
Pharmaron is holding a training webinar on June 20 on the importance of oligonucleotide drugs in modern medicine.
Are you looking to enhance your understanding of DMPK to drive your preclinical research studies forward? Pharmaron invites you to join our webinar series that identifies and answers key DMPK questions that arise during drug discovery and development.
Learn more about the importance of oligonucleotide drugs in modern medicine by registering for this webinar scheduled on Thursday, 20th June 2024 at 8:00 am PDT/ 11:00 am EDT/ 4:00 pm BST. The webinar will discuss practical experience of conducting ADME/DMPK studies with this class of molecules and specific considerations.
By registering once, you will have access to and receive updates for each webinar in the series. Register for the series:
Key Topics Explored:
- Intro to Oligo Bioanalysis
- What are the PK properties of Oligos and how can we influence their distribution?
- M & E – How are 2nd and 3rd Gen oligos cleared?
- Radiosynthesis of Oligos
- What are the options available and considerations needed?
- ADME of Radiolabelled Oligos
- Practical considerations for performing radiolabelled non clinical ADME studies – examples provided
Learn more about our DMPK webinar series and watch previous webinar.